FDA
Rosiglitazone Maleate
The FDA lists this product in 13 strengths and forms.
Composition
- Active ingredients
- ROSIGLITAZONE MALEATE EQ 2MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ROSIGLITAZONE MALEATE 4MG · TabletANDA078825-002 · Tentative approval
- ROSIGLITAZONE MALEATE 8MG · TabletANDA078825-003 · Tentative approval
- ROSIGLITAZONE MALEATE 2MG · TabletANDA078825-001 · Tentative approval
- ROSIGLITAZONE MALEATE 8MG · TabletANDA078658-003 · Tentative approval
- ROSIGLITAZONE MALEATE 2MG · TabletANDA078658-001 · Tentative approval
- ROSIGLITAZONE MALEATE 4MG · TabletANDA078658-002 · Tentative approval
- ROSIGLITAZONE MALEATE 2MG · TabletANDA078695-001 · Tentative approval
- ROSIGLITAZONE MALEATE 4MG · TabletANDA078674-002 · Tentative approval
- ROSIGLITAZONE MALEATE 8MG · TabletANDA078674-003 · Tentative approval
- ROSIGLITAZONE MALEATE 2MG · TabletANDA078674-001 · Tentative approval
- ROSIGLITAZONE MALEATE EQ 8MG BASE · TabletANDA076747-003 · Discontinued
At a glance
- Brand name
- Rosiglitazone Maleate
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Ani Pharms
- Status
- Discontinued
- FDA approval
- 25 Jan 2013
- Application
- ANDA076747-001